14D
0.091
405.6%
CT1
0.001
-50%
SW1
0.015
114.3%
CCE
0.12
-36.8%
KGD
0.024
60%
VFX
0.002
-33.3%
RAS
0.035
52.2%
XGL
0.018
-28%
PGY
0.009
50%
CHM
0.003
-25%
AVM
0.08
48.1%
FGR
0.068
-22.7%
CXU
0.014
27.3%
AUR
0.007
-22.2%
MRQ
0.005
25%
AVW
0.011
-21.4%
NFM
0.015
25%
RLG
0.004
-20%
RDS
0.005
25%
ROG
0.004
-20%
FML
0.985
23.9%
EIQ
0.205
-18%
MML
0.028
21.7%
HMI
0.041
-18%
SIS
0.006
20%
OSX
0.01
-16.7%
TG1
0.031
19.2%
SPX
0.005
-16.7%
RAC
3.04
18.3%
VEN
0.005
-16.7%
RCM
0.065
18.2%
H2G
0.011
-15.4%
AHK
0.36
18%
CGR
0.047
-14.5%
FRS
0.295
18%
M4M
0.006
-14.3%
GHY
0.56
17.9%
TSL
0.006
-14.3%
RRR
0.1
17.6%
VAR
0.006
-14.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH